📗 Cite This Artifact
Nodes of Ranvier
Nodes of Ranvier
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nodes of Ranvier</th>
</tr>
<tr>
<td class="label">Channel</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NaV1.1</td>
<td>SCN1A</td>
</tr>
<tr>
<td class="label">NaV1.2</td>
<td>SCN2A</td>
</tr>
<tr>
<td class="label">NaV1.6</td>
<td>SCN8A</td>
</tr>
<tr>
<td class="label">NaV1.7</td>
<td>SCN9A</td>
</tr>
</table>
Introduction
Nodes Of Ranvier is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Nodes of Ranvier are specialized regions of myelinated axons where the myelin sheath is interrupted, exposing the axonal membrane to the extracellular space. These gaps, typically 1-2 micrometers in length, occur at regular intervals along myelinated fibers and are critical for rapid saltatory conduction of action potentials in the nervous system. In the central nervous system (CNS), nodes are approximately 1 μm in length with internodal distances of 200-1000 μm, while peripheral nervous system (PNS) nodes are slightly longer with shorter internodes. [@waxman1980]
Nodes of Ranvier
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nodes of Ranvier</th>
</tr>
<tr>
<td class="label">Channel</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NaV1.1</td>
<td>SCN1A</td>
</tr>
<tr>
<td class="label">NaV1.2</td>
<td>SCN2A</td>
</tr>
<tr>
<td class="label">NaV1.6</td>
<td>SCN8A</td>
</tr>
<tr>
<td class="label">NaV1.7</td>
<td>SCN9A</td>
</tr>
</table>
Introduction
Nodes Of Ranvier is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Nodes of Ranvier are specialized regions of myelinated axons where the myelin sheath is interrupted, exposing the axonal membrane to the extracellular space. These gaps, typically 1-2 micrometers in length, occur at regular intervals along myelinated fibers and are critical for rapid saltatory conduction of action potentials in the nervous system. In the central nervous system (CNS), nodes are approximately 1 μm in length with internodal distances of 200-1000 μm, while peripheral nervous system (PNS) nodes are slightly longer with shorter internodes. [@waxman1980]
The molecular architecture of the node of Ranvier represents one of the most highly organized structures in the nervous system, with a distinctive composition of voltage-gated sodium channels, potassium channels, cell adhesion molecules, and cytoskeletal proteins. This specialized organization enables the high-speed transmission of electrical signals that underlies all vertebrate nervous system function, from simple reflexes to complex cognitive processes. [@salzer1997]
History and Discovery
The node of Ranvier was first described by French anatomist Louis-Antoine Ranvier in 1878, who observed regular constrictions in myelinated nerve fibers. His detailed histological studies revealed the periodic interruptions in the myelin sheath that now bear his name. Subsequent electron microscopy in the mid-20th century confirmed these observations at the ultrastructural level and began to reveal the complex molecular organization underlying nodal function. [@rasband2021]
The development of patch-clamp electrophysiology in the late 20th century enabled direct measurement of the electrical properties of nodes, while modern molecular biology techniques have revealed the precise protein composition that makes saltatory conduction possible. Today, node of Ranvier research remains at the forefront of neuroscience, with implications for understanding demyelinating diseases, neuropathic pain, and neurological regeneration. [@arancibiacarcamo2017]
Molecular Architecture
Voltage-Gated Sodium Channels
Sodium channels are the hallmark of nodal organization: [@coman2006]
Nav1.2 (SCN2A)
- Expression: Early developmental stages, nodes in CNS
- Function: Action potential initiation
- Properties: Rapid activation and inactivation
- Location: Initial segments, proximal nodes
Nav1.6 (SCN8A)
- Expression: Mature nodes in CNS and PNS
- Function: High-frequency firing, resurgent currents
- Properties: Persistent sodium current
- Location: Main nodal sodium channel
Nav1.7 (SCN9A)
- Expression: Predominantly peripheral neurons
- Function: Pain signaling
- Properties: Slow ramp current
- Location: Peripheral nerve nodes
Potassium Channels
Potassium channels regulate nodal excitability:
- Kv1.1/Kv1.2: Delayed rectifier currents
- KCNQ2/KCNQ3 (M-channel): Subthreshold resonance
- Kir2.1: Inward rectifier (perinodal)
- Kv3.1b: Fast-spiking phenotype
Cell Adhesion Molecules
Cell adhesion molecules anchor the node:
Ankyrin-G (ANK3)
- Scaffold function: Organizes nodal protein complex
- Binding partners: NaV channels, NF186, βIV-spectrin
- Essential role: Node formation and maintenance
Neurofascin-186 (NFASC)
- Interaction: Extracellular partner
- Function: Trans-synaptic adhesion
- Alternative splicing: Multiple isoforms
Contactin (CNTN1)
- PNS-specific: Major nodal adhesion in peripheral nerves
- Function: Sodium channel clustering
Cytoskeletal Proteins
The nodal cytoskeleton provides structural support:
- βIV-spectrin: Links to ankyrin-G
- αII-spectrin: Membrane skeleton
- F-actin: Dynamic cytoskeletal support
- Microtubules: Intracellular transport
Myelin Organization
Paranodal Junctions
Theparanode connects the node to the internode:
- Axoglial junctions: Specialized contact points
- Caspr (CNTNAP1): Paranodal marker
- Caspr2 (CNTNAP2): Juxtaparanodal marker
- Septate-like junctions: Barrier function
Internodal Segments
The internode is the myelinated region:
- Myelin thickness: 10-20 lamellae (PNS), 5-15 (CNS)
- Schwann cells (PNS): Wrap axons with cytoplasm
- Oligodendrocytes (CNS):: Multiple internodes per cell
- Metabolic support: Glucose transport
Juxtaparanodal Region
The juxtaparanode is located adjacent to the paranode:
- Potassium channels: Kv1.1, Kv1.2, Kv1.6
- VGKC complex antibodies: Pathological target
- Lateral diffusion barrier: Protein compartmentalization
Electrophysiology
Saltatory Conduction
Action potentials "jump" between nodes:
Conduction Velocity
Myelination dramatically increases speed:
- Unmyelinated C fibers: 0.5-2 m/s
- Myelinated Aα fibers: 80-120 m/s
- Human peripheral nerve: 50-70 m/s
- Central white matter: 6-20 m/s
Nodal Current Properties
Nodal membranes have unique properties:
- Input resistance: Very high (>100 MΩ)
- Capacitance: Low (~1 μF/cm²)
- Length constant: ~2 mm
- Time constant: ~0.1 ms
Development and Formation
Myelination Timeline
Nodes form during active myelination:
- Embryonic: Initial axonal specification
- Early postnatal: Myelin wrapping begins
- Critical period: Node formation (P10-30 in rodents)
- Maturation: Adult pattern establishment
Mechanisms of Node Formation
Multiple mechanisms orchestrate node assembly:
Molecular Regulation
Key regulators of node formation:
- Lingo-1: Inhibits myelination
- PTPσ: Receptor tyrosine phosphatase
- Notch signaling: Developmental regulation
- Neuregulin-1: Schwann cell development
Disease Involvement
Multiple Sclerosis
MS involves demyelination and node disruption:
- Lesion formation: Inflammatory demyelination
- Node damage: Sodium channel redistribution
- Conduction block: Functional impairment
- Remyelination: Incomplete recovery
Node Changes in MS
Demyelination profoundly affects nodes:
- NaV channel loss: Decreased clustering
- Paranodal disruption: Structural damage
- Axonal degeneration: Progressive loss
- Channel redistribution: Nav1.6 to soma
Charcot-Marie-Tooth Disease
CMT affects peripheral myelinated nerves:
- PMP22 duplication: Most common form (CMT1A)
- Node pathology: Secondary involvement
- Demyelination: Primary mechanism
- Axonal loss: Leads to disability
Amyotrophic Lateral Sclerosis
ALS affects motor neurons and their axons:
- Nodes of motor neurons: Early changes
- Channel alterations: Pathological remodeling
- Axonal transport: Disrupted at nodes
- Vulnerability factors: Molecular mechanisms
Guillain-Barré Syndrome
GBS is an autoimmune neuropathy:
- Anti-MAG antibodies: Target myelin proteins
- Node dysfunction: Conduction failure
- Paranodal damage: Immune-mediated
- Recovery: Variable, often incomplete
Therapeutic Implications
Drug Targets
Nodal proteins as therapeutic targets:
- Sodium channel blockers: Neuropathic pain
- Potassium channel modulators: Excitability
- Immunomodulators: Autoimmune demyelination
- Remyelination promoters: MS therapies
Gene Therapy
Genetic approaches for nodal disorders:
- AAV-NaV1.7: Pain treatment
- Gene replacement: SCN2A mutations
- CRISPR editing: Precise correction
- Antisense oligonucleotides: Channel modulation
Regeneration Strategies
Promoting node recovery:
- Cell transplantation: Olfactory ensheathing cells
- Activity-dependent: Rehabilitation
- Pharmacological: Growth factor delivery
- Biomaterial scaffolds: Bridging lesions
Research Methods
Electrophysiology
Studying nodal function:
- Patch clamp: Single-channel recording
- Extracellular recording: Conduction studies
- In vivo electrophysiology: Animal models
- Human EMG/NCV: Clinical assessment
Imaging
Visualizing node structure:
- Electron microscopy: Ultrastructure
- Immunofluorescence: Protein localization
- Super-resolution microscopy: Nanoscale organization
- Live imaging: Dynamic processes
Molecular Biology
Analyzing nodal components:
- Western blot: Protein expression
- Immunoprecipitation: Protein interactions
- RNA sequencing: Transcriptomic profiling
- Proteomics: Comprehensive analysis
Comparative Biology
Species Differences
Node structure varies across species:
- Mammals: Classic nodal organization
- Birds: Similar to mammals
- Fish: Loose myelination patterns
- Amphibians: Variable internodal lengths
Evolutionary Aspects
Myelin evolution:
- Origin: Vertebrate innovation
- Convergent evolution: Some invertebrates
- Adaptation: Species-specific features
See Also
- [Myelin](/mechanisms/myelin-integrity)
- [Oligodendrocytes](/cell-types/oligodendrocytes) Schwann Cells
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Charcot-Marie-Tooth Disease](/diseases/charcot-marie-tooth-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Sodium Channels](/mechanisms/ion-channel-dysfunction)
- Action Potential
Background
The study of Nodes Of Ranvier has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [NCBI Gene: SCN2A](https://www.ncbi.nlm.nih.gov/gene/6325) - Sodium channel Nav1.2
- [NCBI Gene: SCN8A](https://www.ncbi.nlm.nih.gov/gene/6334) - Sodium channel Nav1.6
- [UniProt: ANK3](https://www.uniprot.org/uniprot/Q12983) - Ankyrin-G
- [Allen Brain Atlas: Node of Ranvier](https://portal.brain-map.org/) - Gene expression data
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | cell-types-nodes-of-ranvier |
| kg_node_id | None |
| entity_type | cell |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-3f84f58675eb |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-nodes-of-ranvier'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-cell-types-nodes-of-ranvier?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Nodes of Ranvier](http://scidex.ai/artifact/wiki-cell-types-nodes-of-ranvier)
http://scidex.ai/artifact/wiki-cell-types-nodes-of-ranvier